IM Therapeutics emerges from stealth with small molecule for T1D

ImmunoMolecular Therapeutics LLC (Broomfield, Colo.) emerged from stealth mode with a small molecule candidate that aims to treat Type I diabetes by preventing the initiation of the

Read the full 270 word article

How to gain access

Continue reading with a
two-week free trial.